Going Forward

ProteomTech is utilizing its Pt-Fold technology for internal programs to develop protein drug candidates. Currently, PTI is focusing on internal development of a diverse portfolio of therapeutic proteins. They are in two categories: (1) improved products of existing protein drugs, and (2) novel proteins with better indications of clinical utilities. These proteins, which are otherwise difficult to recover from E. coli inclusion bodies with other technologies, have been successfully refolded with PTI’s unique refolding process.

Our unique Pt-Fold platform enables ProteomTech to manufacture protein drugs more efficiently and faster than by any other means.

Pt-Fold processes are fully scalable, validatable and approvable for human use.

©2009 ProteomTech, Inc.